Literature DB >> 18221258

Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.

Jicheng Lv1, Hong Zhang, Yang Zhou, Guangtao Li, Wanzhong Zou, Haiyan Wang.   

Abstract

AIM: Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. However, its natural history and risk factors are not well understood. Our aim was to identify the clinical and pathological factors that could predict disease prognosis in Chinese patients.
METHODS: We studied 204 biopsy-diagnosed IgAN patients, who were followed for an average of 6.1 years (range, 4-15 years). Chronic kidney disease (CKD) classified according to the Kidney Disease Outcomes Quality Initiative practice guidelines. Renal pathological lesions were graded single-blindedly according to the Haas classification. The glomerular filtration rate was estimated by the Modification of Diet in Renal Disease equation for Chinese subjects.
RESULTS: Patients with CKD were classified as stage 1 (38.10%), stage 2 (35.40%), stage 3 (13.30%), stage 4 (9.90%) and stage 5 (3.30%). During the follow up, 31 patients had progressed to end-stage renal disease. The renal survival rate following biopsy was 85.1% at the fifth year, and 77.1% at the 10th year. Univariate analysis indicated that patients who were male, had hypertension, proteinuria of more than 1 g/day, renal impairment (estimated glomerular filtration rate, <60 mL/min.1.73 m(2)), and a high histological grading were associated with poor prognosis. Multivariate analysis indicated that the relative risk of renal failure for patients was 3.9 (P = 0.000) for patients with renal impairment, 2.8 (P = 0.019) for patients with hypertension, and 2.0 (P = 0.003) for patients with high histological grading.
CONCLUSION: We described the natural history of IgAN through follow ups of a relatively large cohort of patients. Most patients were biopsied at an early stage; however, the long-term prognosis was still poor. Patients with renal impairment, hypertension and advanced histological involvement had the highest risk for disease progression.

Entities:  

Mesh:

Year:  2008        PMID: 18221258     DOI: 10.1111/j.1440-1797.2007.00898.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  38 in total

Review 1.  Corticosteroid therapy in IgA nephropathy.

Authors:  Jicheng Lv; Damin Xu; Vlado Perkovic; Xinxin Ma; David W Johnson; Mark Woodward; Adeera Levin; Hong Zhang; Haiyan Wang
Journal:  J Am Soc Nephrol       Date:  2012-04-26       Impact factor: 10.121

2.  Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Ritsuko Katafuchi; Kosuke Masutani; Akihiro Tsuchimoto; Hideko Noguchi; Hideki Hirakata; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 8.237

3.  A Haemodialysis Journey from the West to the East.

Authors:  Pearl Pai
Journal:  Kidney Dis (Basel)       Date:  2016-04-01

Review 4.  Novel biomarkers in glomerular disease.

Authors:  Yasar Caliskan; Krzysztof Kiryluk
Journal:  Adv Chronic Kidney Dis       Date:  2014-03       Impact factor: 3.620

5.  Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy.

Authors:  Aliza Thompson; Kevin Carroll; Lesley A Inker; Jürgen Floege; Vlado Perkovic; Sonia Boyer-Suavet; Rupert W Major; Judith I Schimpf; Jonathan Barratt; Daniel C Cattran; Barbara S Gillespie; Annamaria Kausz; Alex W Mercer; Heather N Reich; Brad H Rovin; Melissa West; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2019-01-11       Impact factor: 8.237

6.  Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Kosuke Masutani; Masaharu Nagata; Akihiro Tsuchimoto; Kazuhiko Tsuruya; Takanari Kitazono
Journal:  Clin Exp Nephrol       Date:  2015-02-21       Impact factor: 2.801

7.  Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis.

Authors:  Sean J Barbour; Daniel C Cattran; Gabriela Espino-Hernandez; Michelle A Hladunewich; Heather N Reich
Journal:  Kidney Int       Date:  2015-08-19       Impact factor: 10.612

Review 8.  Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents.

Authors:  Siegtraut Dorothea Herder; Ernst Weber; Almuth Winkemann; Christoph Herder; Hartmut Morck
Journal:  Pediatr Nephrol       Date:  2010-05       Impact factor: 3.714

9.  Renal interstitial infiltration and tertiary lymphoid organ neogenesis in IgA nephropathy.

Authors:  Guangchang Pei; Rui Zeng; Min Han; Panli Liao; Xuan Zhou; Yueqiang Li; Ying Zhang; Ping Liu; Chunxiu Zhang; XiaoCheng Liu; Ying Yao; Gang Xu
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

10.  The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.

Authors:  Shigeru Tanaka; Toshiharu Ninomiya; Ritsuko Katafuchi; Kosuke Masutani; Masaharu Nagata; Akihiro Tsuchimoto; Hideki Hirakata; Takanari Kitazono; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2015-11-12       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.